Hybrid AF™ Therapies Summit – June 28, 2024 (fully booked)

28 June, 2024 - Milano, Italy

The 7th edition of the Hybrid AF™ Therapies Summit is taking place in the city of Milano on June 28, 2024! Join your colleagues for a program covering AF and other cardiac arrhythmias treatment with Hybrid AF™ Therapies.

The program is fully booked.

Led by an international panel of speakers, the event will include sessions and roundtables on latest clinical trial results, best practices, patient selection criteria and procedural considerations.

Audience
Electrophysiologists and Cardiac Surgeons who are interested in developing a Hybrid AF program, or have already started it and would like to further advance their expertise through discussions with peers.

Level
All levels

Faculty
International Faculty

Agenda

The program commences on June 28.

Topics include:

– Pathophysiology and treatment options for persistent and long-standing persistent AF
– Principles and techniques for epicardial ablation and LAA exclusion
– Review of the latest clinical data
– Expert panel discussions
– Opportunities and challenges of developing a Hybrid AF program
– Real-world case debate

Venue
Centro Cardiologico Monzino, Via Carlo Parea 4, 20138 Milano MI, Italy

Accommodation
Hotel bookings will be allocated on an individual basis and you will receive a reservation confirmation by email. Please check your travel details tab in your AF Connect dashboard for your details.

For more information on the programs and registration, please reach out to your AtriCure representatives.

 

 

Register Interest
Day 1
Morning

8:30 am - 8:45 am

Welcome Message

  • Claudio Tondo, MD — Centro Cardiologico Monzino, Milan, Italy

  • Gianluca Polvani, MD — Centro Cardiologico Monzino, Milan, Italy

  • Randall Lee, MD — University of California, San Francisco, USA

8:45 am - 10:30 am

Atrial Filbrillation

    • The Role of Hybrid AF Therapies in Contemporary AF Management
      Syed Ahsan, MD — Barts Heart Centre, London, UK

    • What Is Coming Up? What Is Being Investigated? From Guidelines to Clinical Trials
      Andreu Porta-Sánchez, MD — Hospital Clínic, Barcelona, Spain

    • From Evidence to Clinical Practice
      Kevin Makati, MD — Tampa Cardiac Specialists, Lutz, USA

    • Q&A Open Session With Panelists

10:30 am - 1:00 pm

Hybrid Therapies

  • Claudio Tondo, MD — Centro Cardiologico Monzino, Milan, Italy

  • Gianluca Polvani, MD — Centro Cardiologico Monzino, Milan, Italy

    • Pathophysiology of Stroke and LAA Elimination
      Randall Lee, MD — University of California, San Francisco, USA

    • Introduction to the Convergent Subxiphoid Approach
      Thorsten Hanke, MD — Asklepios Klinikum Harburg, Hamburg, Germany

    • LAA Exclusion in Hybrid Procedures
      Alfonso Agnino, MD — Humanitas Gavazzeni, Bergamo, Italy

    • New EPi-Sense STTM Device. Features and Benefits From First Clinical Cases
      Konstantinos Zannis, MD — Institut Mutualiste Montsouris, Paris, France

    • Lesion Assessment Techniques
      Gianluca Polvani, MD — Centro Cardiologico Monzino, Milan, Italy

    • Case Presentation/Panel Discussion

    • Hybrid TT Ablation. Concept, Evidence and Clinical Practice
      Manuel Carnero Alcázar, MD — Hospital Clínico San Carlos, Madrid, Spain

    • Setting up a Hybrid Program. Journey and Lessons From an Electrophysiologist
      Rukshen Weerasooriya, MD — University of Western Australia, Perth, Australia

    • Health Economics Impact of Hybrid Therapies
      Sandeep Panikker, MD — University Hospitals Coventry and Warwickshire, Coventry, UK

    • Anatomical and Electrophysiological Complexities of the Posterior Wall: 2 Separate Worlds?
      Panel Discussion

Afternoon

1:00 pm - 2:00 pm

Lunch

2:00 pm - 2:30 pm

Hybrid Therapies for Non-AF Patients

  • Carlo de Asmundis, MD — Universitair Ziekenhuis Brussel, Brussels, Belgium

    • IST, VT, Brugada: Incidence/Prevalence/Diagnosis/Available Treatments
      Carlo de Asmundis, MD — Universitair Ziekenhuis Brussel, Brussels, Belgium

    • Procedural Insights: The Sinus Node Sparing Procedure, Epicardial VT Procedure
      Mark La Meir, MD — Universitair Ziekenhuis Brussel, Brussels, Belgium

2:30 pm - 3:00 pm

Hybrid Therapies for Non-AF Patients

  • Andreu Porta-Sánchez, MD — Hospital Clínic, Barcelona, Spain

  • Randall Lee, MD — University of California, San Francisco, USA